Using observational data to inform the design of a prospective effectiveness study for a novel insulin delivery device

References

• American Diabetes AssociationStandards of medical care in diabetes – 2012Diabetes Care201235Suppl 1S11S6322187469
   PubMed Web of Science ®Google Scholar
• BrownJBNicholsGACase-control study of 10 years of comprehensive diabetes careWest J Med20001722859010693367
   PubMedGoogle Scholar
• CDC Diabetes Cost-Effectiveness GroupCost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetesJAMA2002287192542255112020335
   PubMed Web of Science ®Google Scholar
• DoddAHColbyMSBoyeKSFahlmanCKimSBriefelRRTreatment approach and HbA1c control among US adults with type 2 diabetes: NHANES 1999–2004Curr Med Res Opin20092571605161319469695
   PubMed Web of Science ®Google Scholar
• VouriSMShawRFWaterburyNVEggeJAAlexanderBPrevalence of achievement of A1c, blood pressure, and cholesterol (ABC) goal in veterans with diabetesJ Manag Care Pharm201117430431221534641
   PubMed Web of Science ®Google Scholar
• MenzinJKornJRCohenJRelationship between glycemic control and diabetes-related hospital costs in patients with type 1 or type 2 diabetes mellitusJ Manag Care Pharm201016426427520433217
   PubMed Web of Science ®Google Scholar
• ShettySSecnikKOglesbyAKRelationship of glycemic control to total diabetes-related costs for managed care health plan members with type 2 diabetesJ Manag Care Pharm200511755956416137213
   PubMedGoogle Scholar
• BerlowitzDRAshASGlickmanMDeveloping a quality measure for clinical inertia in diabetes careHealth Serv Res2005406 Pt 11836185316336551
   PubMed Web of Science ®Google Scholar
• BlakBTSmithHTHardsMCurtisBHIvanyiTOptimization of insulin therapy in patients with type 2 diabetes mellitus: beyond basal insulinDiabetic Med2012297e13e2022268988
   PubMed Web of Science ®Google Scholar
• GillJMFoyAJLingYQuality of outpatient care for diabetes mellitus in a national electronic health record networkAm J Med Qual2006211131716401701
   PubMed Web of Science ®Google Scholar
• HoergerTJSegelJEGreggEWSaadineJBIs glycemic control improving in US adults?Diabetes Care2008311818617934153
   PubMed Web of Science ®Google Scholar
• AlexanderGCSehgalNLMoloneyRMStaffordRSNational trends in treatment of type 2 diabetes mellitus, 1994–2007Arch Intern Med2008168192088209418955637
   PubMedGoogle Scholar
• HuangESBasuAFinchMFrytakJManningWThe complexity of medication regimens and test ordering for patients with diabetes from 1995 to 2003Curr Med Res Opin20072361423143017559738
   PubMed Web of Science ®Google Scholar
• RubinRRAdherence to pharmacologic therapy in patients with type 2 diabetes mellitusAm J Med20051185A27S34S15850551
   PubMedGoogle Scholar
• KapitzaCFeinSHeinemannLSchleusenerDLevesqueSStrangePBasal-prandial insulin delivery in type 2 diabetes mellitus via the V-Go™: a novel continuous subcutaneous infusion deviceJ Diabetes Sci Technol200821404619885176
   PubMedGoogle Scholar
• PetrakFStriddeELeverkusFCrispinAAForstTPfütznerADevelopment and validation of a new measure to evaluate psychological resistance to insulin treatmentDiabetes Care20073092199220417575092
   PubMed Web of Science ®Google Scholar
• RossSATildesleyHDAshkenasJBarriers to effective insulin treatment: the persistemce of poor glycemic control in type 2 diabetesCurr Med Res Opin201127Suppl 3132021942467
   PubMed Web of Science ®Google Scholar
• PeyrotMRubinRRKrugerDFTravisLBCorrelates of insulin injection omissionDiabetes Care201033224024520103556
   PubMed Web of Science ®Google Scholar
• JacobsonDDiabetes care and management: the patient’s perspectivePaper presented at: American Association of Diabetes Educators 2011 Annual Meeting and ExhibitionAug 2011Las Vegas, NV
   Google Scholar
• RosenfeldCRBohannonNJBodeBThe V-Go™ insulin delivery device used in clinical practice: patient perception and retrospective analysis of glycemic controlEndocr Pract201218566066722548944
   PubMed Web of Science ®Google Scholar
• QuanHSundararajanVHalfonPCoding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative dataMed Care200543111130113916224307
   PubMed Web of Science ®Google Scholar
• HaywardRSManningWGKaplanSHWagnerEHGreenfieldSStarting insulin therapy in patients with type 2 diabetes: effectiveness, complications, and resource utilizationJAMA199727820166316699388085
   PubMed Web of Science ®Google Scholar
• NicholsGAKimesTMHarpJBKouTDBrodoviczKGGlycemic response and attainment of A1C goals following newly initiated insulin therapy for type 2 diabetesDiabetes Care201235349549722279033
   PubMed Web of Science ®Google Scholar
• WuNAagrenMBoulangerLFriedmanMWilkeyKAssessing achievement and maintenance of glycemic control by patients initiating basal insulinCurr Med Res Opin201229101647165622937724
   PubMed Web of Science ®Google Scholar
• NicholsGAGlauberHSBrownJBType 2 diabetes: incremental medical care costs during the 8 years preceding diagnosisDiabetes Care200023111654165911092288
   PubMed Web of Science ®Google Scholar
• HermanWHEdelsteinSLRatnerREEffectiveness and cost-effectiveness of diabetes prevention among adherent participantsAm J Manag Care201319319420223544761
   PubMed Web of Science ®Google Scholar
• HermanWHThe economics of diabetes preventionMed Clin North Am201195237338421281839
   PubMed Web of Science ®Google Scholar
• Diabetes Prevention Program Research GroupThe 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention: an intent-to-treat analysis of the DPP/DPPOSDiabetes Care201235472373022442395
   PubMed Web of Science ®Google Scholar
• The ORIGIN Trial InvestigatorsBasal insulin and cardiovascular and other outcomes in dysglycemiaN Engl J Med20122674319328
   Google Scholar
• DavisSNWeiWGargSClinical impact of initiating insulin glargine therapy with disposable pen versus vial in patients with type 2 diabetes mellitus in a managed care settingEndocr Pract201117784585221550952
   PubMed Web of Science ®Google Scholar